Salarius Pharmaceuticals
TX - Houston
PharmaceuticalFocus: Epigenetic Enzymes
Salarius Pharmaceuticals is a life sciences company focused on Epigenetic Enzymes.
NeurologyRare Diseases
Funding Stage
PUBLIC
Total Funding
$160M
Open Jobs
0
Pipeline & Clinical Trials
SP-2577
SCCOHTClinical Trials (1)
NCT04611139Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic Cancers
Phase 1Phase 1
Clinical Trials (1)
NCT05979857Study of SP-3164 in Relapsed or Refractory Non-Hodgkin's Lymphoma
Phase 1Seclidemstat
Ewing SarcomaClinical Trials (1)
NCT03600649Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas
Phase 1SP-2577 Seclidemstat
Advanced Solid TumorsClinical Trials (1)
NCT03895684Phase 1 Trial of the LSD1 Inhibitor SP-2577 (Seclidemstat) in Patients With Advanced Solid Tumors
Phase 1Seclidemstat
Ewing SarcomaClinical Trials (1)
NCT05266196A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)
Phase 1/2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 5 clinical trials
Top TAs: Oncology